Toll-like receptors (TLR) are members of a highly conserved group of receptors wh1ch recognize conserved molecular aspects of m1crobes. The purpose of these experiments were to ascertain the effects of the administration of the TLR 9 agonist, CpG, on the colonization of neonatal swine with Salmonella.
Introduction
Salmonella is an important food-borne pathogen in humans (Voetsch et at., 2004) . Poultry, swine, and cattle are known carriers of Salmonella and are important vectors of transmission of Salmonella to humans (Patrick et a/., 2004) . Initial interactions between cells of the host innate immune system and pathogens, such as Salmonella, depends on the host's recognition of evolutionarily conserved molecules unique to a certain class of microbes called pathogenassociated molecular patterns (PAMPs) (Fearon & Locksley, 1996; Akira, 2001 ; Janeway & Medzhitov, 2002) . These PAMPs are recognized by the cells of the innate system via pattern recognition receptors (PRRs), such as the Toll-like receptors (TLR). and this recognition initiates signaling pathways within the cell that result in the production and release of cytokines. chemokines, and activation of the cell itself (Imler & Hoffman 2001 ; Janeway & Medzhitov 2002 , Kopp & Medzhitov 2003 . The recognition and subsequent release of cytokines aids m the direction of the acquired arm of the immune system, leading the response towards either a T H1. cell-mediated response or a T H2. antibody-mediated response (Medzhitov & Janeway 1997a,b; Romagnani 1992) . Bacterial DNA contains unmethylated portions of its sequence that are conserved regions called CpG DNA. CpG DNA is recognized by the mammalian innate immune system through TLR 9 (Hemmi et al, 2000 : Bauer et al, 2001 . Previous studies have Indicated that CpG DNA can stimulate neutrophils of weaned p1gs and protect weaned pigs against a laboratory challenge with Salmonella choleraesuis (Genovese et al., Safe Pork 2005) . In addition, CpG DNA have been found to stimulate the avian immune system and show protective effects against Salmonella challenge (He et al., 2005 ) . The purpose of the present studies was to observe the effects of the TLR9 agonist, CpG DNA, in a laboratory challenge model of Salmonella choleraesuis (SC) mfect1on.
Materials and metods
The sequence of the CpG DNA was as follows:
Piglets in the CpG group received 1.0 mg CpG DNA in 2ml of phosphate-buffered saline (PBS) by oral gavage. Pigs in the SC infected control group received an oral dose of 2ml PBS. Piglets were we1ghed , ear-tagged, and g1ven their respective treatment withm 24 hours after birth . The day the treatment was administered was designated day 0. On day 5 post-treatment, all piglets were weighed; piglets in infected ~roups were orally administered 2 ml of phosphate-buffered saline solut1on (PBS) contaimng 10 colony-form1ng units (cfu) of Salmonella choleraesws (SC). Daily rectal swabs were taken from all groups and cultured for the presence of SC following established procedures. On day 10 post-treatment, pigs were weighed , then euthanized and sections of the gut and lymph nodes were cultured for the presence of SC. The cecum , colon , and rectum tissues and the luminal contents were cultured for the presence and enumerat1on of SC, respectively. In addition , the liver, spleen , and ileocecal lymph nodes were cultured for the presence of SC.
Resu lts
Results of the SC enumerat1on studies are presented in Table 1 . Treatment of neonatal swine with CpG within 24 hr after birth reduced the number of SC recovered from all three areas of the gut sampled and enumerated . In both the colon and the cecum , SC cfu were reduced by at least one log 10. No SC was recovered from the rectum during enumeration studies in the p1gs treated with CpG (a 31og10 reduction). Results of ennched samples of the gut and tissues are presented 1n Figure 1 . In the spleen, lymph nodes, colon , cecum, and rectum, the number of pigs positive for SC upon enrichment was reduced m the CpG treatment group compared to the SC control group. Again , p1gs in the CpG group showed no recovery of SC 1n the rectum samples. Daily rectal swab data are presented in Figure 2 . On the first day of sampling (Day 6), pigs m the CpG group had 40% SC positive rectal swabs compared to 20% in the SC control group. However, on Day 7, 8, 9, and 10 the CpG group had greatly reduced recovery of SC in rectal swab samples compared to the SC control group. 
Discussion
In this study, CpG DNA reduced fecal shedding and gut and tissue colonization by Salmonella choleraesuis in neonatal pigs. These results are similar to previous studies of CpG DNA treatment and reductions in Salmonella colonization in weaned pigs (Genovese et al., Safe Pork 2005) . Although preliminary, these results indicate that CpG DNA could be effective in reducing Salmonella colonization of the swine gut and perhaps reduce the load of Salmonella moving through swine during later stages of production. However, more research is needed to form any conclusions on the effectiveness of CpG DNA treatment in neonatal pigs and subsequent effects on Salmonella carriage in later production stages. CpG DNA has been shown as a potent stimulator of the innate immune system in poultry and in mammals (He et al., 2005; Genovese et al., SafePork 2005) . The use of TLR agonists on their own or in combination with vaccines as adjuvants may provide effective agents for reducing both foodborne and animal disease pathogens in food animals.
Conclusions
The results of these studies prov1de a basis for further characterization of TLR agonists effects against pathogens in swine. CpG DNA treatment of neonatal pigs within 24 hr after birth reduced the levels of Salmonella choleraesuis in the cecum, colon, and rectum by at least one log1 0 and reduced the number of pigs positive for Salmonella choleraesuis after enrichment in the spleen and lymph nodes. Treatment of neonatal pigs with CpG DNA also reduced the number of pigs shedding Salmonella choleraesuis in their feces. Further studies are needed to determine the overall effectiveness of CpG DNA administration to neonatal pigs in reducing Salmonella colonization of the gut and of tissues and its effects throughout later stages of swine production.
